Ligand validation:8IRA

PL9: 2,3-DIMETHYL-5-(3,7,11,15,19,23,27,31,35-NONAMETHYL-2,6,10,14,18,22,26,30,34-HEXATRIACONTANONAENYL-2,5-CYCLOHEXADIENE-1,4-DIONE-2,3-DIMETHYL-5-SOLANESYL-1,4-BENZOQUINONE

PL9 is a Ligand Of Interest in 8IRA designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IRA_PL9_d_406	82%	41%	0.106	0.961	0.65	1.63	1	17	0	0	100%	0.4
8IRA_PL9_D_405	81%	41%	0.111	0.963	0.62	1.64	2	18	0	0	100%	0.4
8IRA_PL9_a_412	21%	32%	0.225	0.831	0.65	2	2	22	0	0	100%	0.4
8IRA_PL9_A_414	18%	30%	0.229	0.817	0.68	2.08	2	25	0	0	100%	0.4
5WS6_PL9_D_405	97%	37%	0.055	0.967	0.69	1.76	2	21	0	0	100%	1
5B5E_PL9_d_406	96%	33%	0.054	0.965	1.05	1.59	4	12	0	0	100%	1
5GTI_PL9_d_405	96%	36%	0.053	0.962	0.64	1.86	2	22	0	0	100%	1
5V2C_PL9_d_407	96%	34%	0.069	0.978	1.27	1.32	8	10	0	0	100%	1
5B66_PL9_D_412	93%	35%	0.077	0.97	1.06	1.51	3	12	0	0	100%	1
5ZZN_PL9_D_407	92%	34%	0.081	0.973	1.11	1.47	6	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.